Seres Therapeutics paid its 5 named executives $6.1M in total in FY2025 (Dec).
Pay of each named executive
Eric D. ShaffFormer President and Chief Executive Officer
| FY2025 (Dec) | |||||||
| FY2024 (Dec) | |||||||
| FY2023 (Dec) | |||||||
| FY2022 (Dec) | Not disclosed |
4 years
Thomas J. DesRosierFormer Co-President and Co-Chief Executive Officer and current Executive Vice President and Chief Legal Officer
| FY2025 (Dec) | |||||||
| FY2024 (Dec) |
2 years
Marella ThorellFormer Co-President and Co-Chief Executive Officer and current Executive Vice President and Chief Financial Officer
| FY2025 (Dec) |
1 year
Teresa L. Young, Ph.D.Former Executive Vice President and Chief Commercial and Strategy Officer
| FY2025 (Dec) | |||||||
| FY2023 (Dec) |
2 years
Matthew Henn, Ph.D.President and Chief Scientific Officer
| FY2025 (Dec) |
1 year
CEO pay against the pay peers
In FY2024 (Dec), the median CEO pay of the 5 peers with pay on file was $4.2M. CEO pay of Seres Therapeutics for that year is not on file.
- 1Mirum Pharmaceuticals
- 2Travere Therapeutics
- 3Atea Pharmaceuticals
- 4Arcutis Biotherapeutics
- 5Enanta Pharmaceuticals
- 6Seres TherapeuticsThis companyNot disclosed
- 7Amylyx PharmaceuticalsNot disclosed
- 8ArdelyxNot disclosed
- 9Atara Biotherapeutics Inc.Not disclosed
- 10Chinook Therapeutics, Inc.Not disclosed
- 11Collegium PharmaceuticalNot disclosed
- 12Crinetics Pharmaceuticals, Inc.Not disclosed
- 13Deciphera Pharmaceuticals, Inc.Not disclosed
- 14ImmunoGen, Inc.Not disclosed
- 15Ironwood PharmaceuticalsNot disclosed
- 16Karyopham Therapeutics, Inc.Not disclosed
- 17MacrogenicsNot disclosed
- 18Revance Therapeutics, Inc.Not disclosed
- 19Rhythm PharmaceuticalsNot disclosed
Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.